Synthetic analogue of insulin-like growth factor 1 (IGF-1) studied in cellular growth and signalling research Engineered with an extended amino acid sequence and reduced binding affinity to IGF binding proteins compared to native IGF-1 Investigated in laboratory models involving cell proliferation, differentiation, and metabolic signalling pathways Supplied as high purity lyophilised peptide powder Form: Lyophilised peptide powder Strength: 1mg Purity: 99% Verification: HPLC and Mass Spectrometry
overexpressed miR-340-5p in the myocardium by direct myocardial injection of AVV-9 containing miR-340-5p precursor, which targeted inhibition of MyD88 and thus restored declining GSH levels, alleviated insult of cardiac function and oxidative injury induced by sepsis in the hearts of mice [253]
References Witschi A, Reddy S, Stofer B, Lauterburg BH
This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as a drug, food, or cosmetic
A typical dose ranges from 250 to 500 mg per serving
J Clin Exp Neuropsychol